Evan Loh
2018
In 2018, Evan Loh earned a total compensation of $1.8M as Chief Executive Officer at Paratek Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $288,000 |
|---|---|
| Salary | $480,000 |
| Stock Awards | $1,011,725 |
| Other | $21,434 |
| Total | $1,801,159 |
Loh received $1M in stock awards, accounting for 56% of the total pay in 2018.
Loh also received $288K in non-equity incentive plan, $480K in salary and $21.4K in other compensation.
Rankings
In 2018, Evan Loh's compensation ranked 6,257th out of 14,244 executives tracked by ExecPay. In other words, Loh earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,257 out of 14,244 | 56th |
Division Manufacturing | 2,395 out of 5,759 | 58th |
Major group Chemicals And Allied Products | 894 out of 2,122 | 58th |
Industry group Drugs | 750 out of 1,811 | 59th |
Industry Pharmaceutical Preparations | 582 out of 1,385 | 58th |
Source: SEC filing on April 23, 2021.
Loh's colleagues
We found two more compensation records of executives who worked with Evan Loh at Paratek Pharmaceuticals in 2018.